Atlas Trials

An Observational Study of Fecal Calprotectin as Clinical Tool in Monitoring Moderate-to-severe Crohn's Disease on Adalimumab Induction Therapy: a KoRean Experience (FAIR)

Clinical trial NCT01759264 · COMPLETED

Trial details

NCT number
NCT01759264
Sponsor
AbbVie (prior sponsor, Abbott)
Status
COMPLETED
Study type
OBSERVATIONAL
Crohn's Disease
Start date
2013-01-01
Primary completion
2014-05-01
Enrollment
101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.